GlassScriptPhysician profile
Brandon Cole Mccarty
NPI 1730700428
$2,488.81
in general payments reported to CMS, 2019-2025
9 companies · $2,080 in 2025
The $2,080 reported for 2025 was more than what 90% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $247 · 2024: $162 · 2025: $2,080.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,443 · Travel and Lodging: $1,046.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,443.04 |
| Travel and Lodging | $1,045.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,655.65 | 2025 | Indigo System, Ruby Coil |
| Imperative Care, INC | $234.93 | 2024-2025 | Symphony Catheter |
| Sirtex Medical INC | $130.82 | 2023 | Sir-Spheres Microspheres |
| Galvanize Therapeutics, INC | $116.00 | 2023 | Aliya System |
| Organogenesis INC. | $115.68 | 2025 | Puraply Wound Matrix, Nushield, Apligraf |
| Shockwave Medical, INC | $85.54 | 2025 | |
| Terumo Medical Corporation | $79.79 | 2025 | Glidesheath Slender, Navicross, Azur Cx Detachable |
| Cardiva Medical, INC. | $48.27 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Trisalus Life Sciences, INC. | $22.13 | 2025 | Trinav Infusion System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Mccarty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.